EUROPEAN MULTIDISCIPLINARY ON UROLOGICAL CANCERS..

10th European Multidisciplinary Congress on Urological Cancers - EMUC 2018

 

8-11 November 2018 Amsterdam
Close
N. Poster
Poster title
Applicant name
Status
  P-005 Follow-up and long-term comparison of the 8 and 12 cylinder scheme in prostate biopsy Pau Sarrió-Sanz Received Received
  P-006 Improving Standard Trans-Rectal Prostate Biopsy Results Using High Resolution Micro-Ultrasound Real-Time Targeting for Suspicious Areas Robert Sandler Received Received
  P-007 Initial Clinical Experience with 29 MHz Micro-Ultrasound for Real-Time Targeted Prostate Biopsies Robert Sandler Received Received
  P-008 Where Do Micro-Ultrasound and MRI Find Prostate Cancer? A Target Localization Study Robert Sandler Received Received
  P-009 Learning curve and distribution of PI-RADS score in a population based series of Norwegian men examined with a mpMRI detection protocol Martin Landquist Received Received
  P-010 Assessment of ADC measurement using mpMRI in patients with low-risk prostate cancer (PCa) after radical prostatectomy (RP) Dmitry Goncharuk Received Received
  P-011 Does high PIRADS V2 Score on a pre biopsies Multiparametric MRI scan suggest high-Gleason score prostate cancer? Israr Khan Received Received
  P-013 Prostate cancer incidence related to favourable free/total PSA ratio. Virginia del Rosario Rodriguez Received Received
  P-020 Validation and face to face comparison of three preoperative nomograms for prediction of lymph node invasion before radical prostatectomy Angeles Sanchis-Bonet Received Received
  P-021 Should residents perform Laparoscopic Radical Prostatectomy? Datebase analysis rodriguez lopez sabela Received Received
  P-023 Increasing Time from Diagnosis to Radical Prostatectomy (RP-interval) is Not Associated with Adverse Oncological Outcomes: Implications for cancer patient pathways (CPPs) Kirsti Aas Received Received
  P-040 Correlation between the location of the index tumour and the location of positive lymph nodes in high-risk prostate cancer. A monocentric positive lymph node mapping study Brecht Jacobs Received Received
  P-041 Effect of PectaSol-C modified citrus pectin (P-MCP) treatment (tx) on PSA Dynamics in non- metastatic Biochemically Relapsed Prostate Cancer (BRPC) patients (pts): Results of a prospective Phase II Study Charles Hartmann Received Received
  P-048 Post-docetaxel survival in metastatic castration-resistant prostate cancer (mCRPC) is improving in the Netherlands Malou Kuppen Received Received
  P-049 Efficacy of Abiraterone acetate plus Prednisone and Enzalutamide sequences in men with metastatic castration-resistant prostate cancer: Systematic review and meta-analysis Paola Moreno Received Received
  P-051 Potential prognostic factors for metastatic castration resistant prostate cancer with Abiraterone Acetate Cecília Maria de Melo Alvim Moreira Received Received
  P-053 Incidence of urological complications in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first line abiraterone and enzalutamide JAVIER LORCA Received Received
  P-055 Enzalutamide in metastatic castration resistant prostate cancer, a single center experience Rita Paiva Received Received
  P-056 A single-center experience with abiraterone acetate in metastatic castration resistant prostate cancer Ana Afonso Received Received
  P-058 Survival impact of the management of medical and urological complications during treatment with 1st line abiraterone (A) or enzalutamide (E) in patients with metastatic castration-resistant prostate cancer (mCRPC) Juan Jose Serrano Domingo Received Received
  P-061 Prognostic impact of end of radiotherapy PSA (EORT-PSA) on long-term outcomes in patients with N1 prostate cancer (PC) Trude Wedde Received Received
  P-063 Prostate volume reduction in patients treated with Abiraterone and Enzalutamide: The forgotten outcome in Clinical trials Sara Alvarez Rodríguez Received Received
  P-064 Exercise prescription dose for castration resistant prostate cancer patients: A phase I prescription dose escalation trial Renée Bultijnck Received Received
  P-067 Risk of postoperative upstaging or upgrading among men with low-risk familial prostate cancer: PCBaSe Sweden Fredrik Jansson Received Received
  P-072 Enzalutamide with or without prior anti-androgen treatment for castration resistant prostate cancer (CRPC): Results from the Dutch CAPRI registry Malou Kuppen Received Received
  P-082 Multicenter registry of CRPC patients: Clinical characteristics and natural history of the disease Victor Jose Valencia Guadalajara Received Received
  P-087 Isolation and characterization of urine exosomes for using as diagnostic biomarkers in Prostate Cancer Angeles Sanchis-Bonet Received Received
  P-095 MRI for assessment of inferior vena cava wall invasion by renal cell carcinoma with vena cava thrombi Tim van Oostenbrugge Received Received
  P-100 Dynamics of markers of acute kidney injury in renal cell carcinoma patients after laparoscopic partial nephrectomy under warm ischemia of the kidney Sergey Dimitriadi Received Received
  P-115 Overall and progression free survival time in mRCC patients Clinicopathological risk group analysis Joanna Huszno Received Received
  P-116 A lower psoas muscle volume correlates with a higher recurrence rate in male clear cell renal cell carcinoma patients Go Noguchi Received Received
  P-123 Increased activation of mammalian target of rapamycin pathway in renal cell carcinoma arising in native kidneys of dialyzed patients Ryuichi Mizuno Received Received
  P-135 Does neoadjuvant chemotherapy affect postoperative complication rates in elderly patients treated with radical cystectomy for bladder cancer? Ryuichi Mizuno Received Received
  P-136 Could adjuvant chemotherapy have additional therapeutic benefit in muscle invasive bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy? Ryuichi Mizuno Received Received
  P-149 Monopolar transurethral resection of bladder tumors preformed by a urology resident: Is it safe for the patient? Francisco José Damas Arroyo Received Received
  P-152 Predictors for development 30-day complications after radical cystectomy (RC) Denis Ledyaev Received Received
  P-153 Pre-treatment lymphocytopenia predicts poor prognosis for patients with metastatic urothelial carcinoma treated with platinum-based first-line chemotherapy Susumu Umemoto Received Received
  P-163 Expression of the microRNAs miR-100, miR-138 y miR-let-7c in non-muscle invasive bladder cancer: clinicopathological significance and prognostic value ALVARO SANCHEZ GONZALEZ Received Received
  P-165 The role of frozen section examination (FSE) during inguinal exploration in 1052 patients with inconclusive testicular lesions Christian Fankhauser Received Received
  P-170 Clinical analysis of extragonadal germ cell tumors in our hospital Sohgo Tsutsumi Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
00:10
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

10th European Multidisciplinary Congress on Urological Cancers - EMUC 2018

 

8-11 November 2018 Amsterdam
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 08/11/2018 TO 08/11/2018
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert